Bioelectronics Corp (BIEL)

[Boricka]

I am assuming the loss of sales was due to Boots. They have little distribution and we are aware they lost OTC Boots. It will take years to replace these sales as they hire a force and solicit Drs. one by one, hopeful the write the script. If you combine this with the fact that each region determines if they will reimburse for the Actipatch, the "decision" to move from OTC demonstrates a serious lack of knowledge of the market. The declining sales, the market, has proven this to be a terrible decision for the company and it's shareholders.

We can all have our opinions, the only opinion that matters is the market. The market has spoken loud and clear through ever declining sales.